MANAGEMENT 

Dr. Ingo Röhl

Dr. Ingo Röhl
Managing Director

Ingo started his career as Research Associate at the Riedel de Haën AG. He then studied Chemistry and, after completion of his Ph.D. at the University of Oldenburg, worked as Scientist at the Noxxon Pharma AG.

Ingo joined Alnyam Europe AG in 2003 where he served as Head of Analytics and built up the analytical department. He held a position as Associate Director at the Roche Kulmbach GmbH and as Senior Director Analytics and Bioanalytics at the Axolabs Kulmbach GmbH.

Ingo has more than 20 years of experience in the field of RNA drug development and (bio-) analytics. He has published more than 20 peer-reviewed articles and book chapters and is inventor on more than 10 patent applications.


Friedrich Sanders

Friedrich Sanders,
Managing Director Finance

After working as a trainee with Deutsche Bank, Friedrich graduated with a degree in business administration from the University of Passau in Germany. He then worked for Diehl Group and was in charge of finance and controlling. Friedrich later served as CEO and CFO in a number of producing and servicing companies, gaining comprehensive experience in performance management and cultural development.

Dr. Hans-Peter Vornlocher

Dr. Hans-Peter Vornlocher,
Managing Director Research

Hans-Peter studied Biology at the University Erlangen, Germany, and after obtaining his Ph.D. in Biochemistry from the University Bayreuth, Germany, he held a postdoctoral position at the University of California in Davis, CA, for three years.

Prior to joining Ribopharma AG as Head of Biochemistry in 2001, Hans-Peter worked as a Senior Scientist in Prof. Lührmann's departments at the Institute for Molecular Biology and Tumor Research in Marburg and at the Max-Planck-Institute for Biophysical Chemistry in Göttingen, Germany. At Alnylam Europe AG Hans-Peter served as VP Research and Managing Director Research, a position he also held at Roche Kulmbach GmbH. 

Hans-Peter has more than 20 years experience in the field of RNA research. He has published more than 45 peer reviewed articles, reviews and book chapters and is inventor on more than 30 patents.